Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).

Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).

BACKGROUND: Venous thromboembolism comprising pulmonary embolism and deep vein thrombosis is a common condition with an incidence of approximately 1 per 1,000 per annum causing both mortality and serious morbidity. The principal aim of treatment of a venous thromboembolism with heparin and warfarin...

Полное описание

Библиографические подробности
Главные авторы:	Tullett, J, Murray, E, Nichols, L, Holder, R, Lester, W, Rose, P, Hobbs, F, Fitzmaurice, D
Формат:	Journal article
Язык:	English
Опубликовано:	BioMed Central 2013

Схожие документы

ExACT: Extended anticoagulation treatment for VTE: a randomised trial
по: Fitzmaurice, D, и др.
Опубликовано: (2011)

A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)
по: Bradbury, C, и др.
Опубликовано: (2019)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
по: Sake J. van der Wall, и др.
Опубликовано: (2018-11-01)

Extended anticoagulation for VTE: what evidence justifies it?
по: Anushka Walia, и др.
Опубликовано: (2023-08-01)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
по: Bethany Samuelson Bannow, и др.
Опубликовано: (2021-07-01)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
по: Walter Ageno, и др.
Опубликовано: (2021-02-01)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
по: Wei Xiong, и др.
Опубликовано: (2023-01-01)

VTE epidemiology and challenges for VTE prevention at the population level
по: Sigrid K. Brækkan, и др.
Опубликовано: (2023-03-01)

Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysis
по: Shuangshuang Ma, и др.
Опубликовано: (2024-02-01)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
по: Ramón Lecumberri, и др.
Опубликовано: (2021-07-01)

SPECIFICITY OF ANTICOAGULANT CHOICE FOR VTE PROPHYLAXES AFTER MAJOR ORTHOPEDIC SURGERY- THE VIEW OF CLINICAL PHARMACOLOGISTS
по: S. A. Bozhkova
Опубликовано: (2011-03-01)

On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease
по: Sylvia Haas, и др.
Опубликовано: (2022-10-01)

Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study
по: Noémie Kraaijpoel, и др.
Опубликовано: (2021-01-01)

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE
по: Walter Ageno, и др.
Опубликовано: (2017-06-01)

VTE risk assessment in pregnancy
по: Karl Ewins, и др.
Опубликовано: (2020-02-01)

Assessing the prevalence of nitrous oxide usage in patients aged 35 years or under presenting with unprovoked VTE between 2021-2023
по: Christine Joerres, и др.
Опубликовано: (2024-09-01)

HOW TO TREAT VTEC IN CANCER PATIENTS IN THE ACUTE PERIOD? EXTENDED TREATMENT. THE ROLE OF DIRECT ORAL ANTICOAGULANTS. THE RESULTS OF HOKUSAI VTE CANCER STUDY
по: Yulia A. Fedotkina
Опубликовано: (2018-12-01)

Routine Postoperative Aspirin for VTE Chemoprophylaxis in Primary Total Ankle Arthroplasty
по: Verinder Sidhu, и др.
Опубликовано: (2022-11-01)

Self management of oral anticoagulation: randomised trial.
по: Fitzmaurice, D, и др.
Опубликовано: (2005)

Duration of anticoagulant treatment for unprovoked deep-vein thrombosis – is prolonged long enough?
по: Menno V. Huisman, и др.
Опубликовано: (2019-07-01)

A Call to Leadership: New VTE Treatment and Prevention Guidelines
по: Omar L. Esponda MD, и др.
Опубликовано: (2024-04-01)

MODIFICATION OF LITHIUM TANTALATE CRYSTALS BY HIGH-TEMPERATURE TREATMENT OF VTE
по: M.N. Palatnikov, и др.
Опубликовано: (2015-11-01)

Recommendations from the ICM-VTE: general
по: Parvizi, J, и др.
Опубликовано: (2022)

Recommendations from the ICM-VTE: trauma
по: Ahn, J, и др.
Опубликовано: (2022)

Nitrous oxide and VTE – no laughing matter
по: Lucy A. Norris, и др.
Опубликовано: (2024-09-01)

Care Pathway of Venous Thromboembolism (VTE)
по: Liselotte van Dijk, и др.
Опубликовано: (2024-07-01)

Metabolomic Profile in Venous Thromboembolism (VTE)
по: Beata Franczyk, и др.
Опубликовано: (2021-07-01)

Prevention of VTE in orthopedic surgery patients
по: Federico Spandonaro, и др.
Опубликовано: (2013-10-01)

Risk Assessment for Cancer-Associated VTE
по: Alok A. Khorana, MD
Опубликовано: (2021-09-01)

Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2
по: Nobutaka Ikeda, и др.
Опубликовано: (2024-11-01)

Challenges in Management of VTE in Children With Cancer: Risk Factors and Treatment Options
по: Nasrin Samji, и др.
Опубликовано: (2022-04-01)

Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis
по: Alessandro Laganà, и др.
Опубликовано: (2024-04-01)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
по: Muzamil Hamid Hussain MBBS, и др.
Опубликовано: (2023-06-01)

Are we preventing VTE in patients with an infective exacerbation of chronic obstructive pulmonary disease - low adherence to VTE prophylaxis guidelines
по: Anmol Khanna
Опубликовано: (2016-12-01)

Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis
по: Ben van Hout, и др.
Опубликовано: (2020-07-01)

Self-management of anticoagulation: a randomized trial (SMART)
по: Fitzmaurice, D, и др.
Опубликовано: (2004)

VTE in ICU: Lessons from COVID-19
по: Xu Chu, и др.
Опубликовано: (2022-10-01)

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
по: Amaia Iñurrieta, и др.
Опубликовано: (2018-10-01)

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
по: Francis Couturaud, и др.
Опубликовано: (2019-07-01)

Reassessing the Risk of Venous Thromboembolism (VTE) Events in Women
по: Changhuai He MD, и др.
Опубликовано: (2024-12-01)